News & Trends - MedTech & Diagnostics
Baxter’s digital health data demonstrates patient benefits and cost-savings on World Kidney Day
MedTech News: Baxter Healthcare, a global leader in dialysis care, announced today its support for World Kidney Day 2021 “Living Well with Kidney Disease” with new economic modelling in support of remote patient management technology for home-based peritoneal dialysis.
The Baxter sponsored paper “Cost Consequence Analysis of Remote Patient Management with HomeChoice Claria with Sharesource Platform for Automated Peritoneal Dialysis Patients in the Australian Setting” published by the International Society for Pharmacoeconomics and Outcomes
Research (ISPOR) estimated a reduction in hospital episodes and potential financial savings to the healthcare system from Baxter Sharesource remote patient management technology for APD.
Over a 12-month period, for each 100 people on two-way remote patient monitoring by Sharesource while undergoing APD, the estimated reduction in hospitals episodes is 36 and potential savings is approximately $AU324,488 compared to traditional APD.
In support of the World Kidney Day organisation and “Living Well with Kidney Disease”, Baxter Australia General Manager, Steven Flynn, said increased education and awareness about kidney disease was an important part of helping patients to live well.
“Baxter Healthcare is proud to support the World Kidney Day organisation and the Living Well with Kidney Disease campaign,” Mr Flynn said.
“Kidney disease is a growing social, economic and health problem globally. As a local Australian manufacturer of dialysis solutions, Baxter is all too aware of the impacts of kidney disease on patients, their families, clinicians and the sustainability of the healthcare system.”
“Collaboration among patient groups, healthcare providers, policy makers and industry is needed to increase education, awareness and patient empowerment to live well with kidney disease.”
News & Trends - Pharmaceuticals
Roche’s immunotherapy drug shows promising results for Australian patients with rare blood cancer
Pharma News: Roche’s immunotherapy drug has shown high response rates in patients with a rare form of blood cancer that […]
MoreNews & Trends - Pharmaceuticals
Government seals deal with industry for rare cancer therapy
Pharma News: Australian children and young adults diagnosed with high-risk neuroblastoma will continue to receive free access to a promising, […]
MoreNews & Trends - MedTech & Diagnostics
Abbott showcases leadless pacemaker system to local stakeholders
MedTech & Diagnostics News: Leadless pacemakers are promising alternatives to transvenous pacing. Abbott hosted a stakeholder event at the recent […]
MoreNews & Trends - Pharmaceuticals
Australian scientists pivotal in new drug class from BMS
Pharma News: The first new class of drug for schizophrenia in decades has been approved, offering a fresh approach by […]
More